Issued Patents 2018
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10131677 | 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta | 2018-11-20 |
| 10105370 | 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace | 2018-10-23 |
| 10081631 | 2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta | 2018-09-25 |
| 10071086 | 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace | 2018-09-11 |
| 10052331 | 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta | 2018-08-21 |
| 10023572 | 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta | 2018-07-17 |
| 10016406 | Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof | David Mark Wallace, Sunil Kumar KC | 2018-07-10 |
| 9994563 | Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof | David Mark Wallace, Sunil Kumar KC | 2018-06-12 |
| 9951053 | γ-diketones as Wnt/β-catenin signaling pathway activators | Sunil Kumar KC, David Mark Wallace, Charlene F. Barroga | 2018-04-24 |
| 9908867 | 3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof | Sunil Kumar KC | 2018-03-06 |
| 9889140 | 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace, Jianguo Cao, Chandramouli Chiruta | 2018-02-13 |
| 9884053 | β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators | Sunil Kumar KC, David Mark Wallace, Charlene F. Barroga | 2018-02-06 |
| 9855272 | 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof | Sunil Kumar KC, David Mark Wallace | 2018-01-02 |